GREGORY HEADLEY: Open Payments
NPI 1013424886 · HAZEL GREEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,484 in 131 payments from 27 companies in 2025. Trend: 2023 $1,888 · 2024 $2,618 · 2025 $2,484
Food & beverage: $2,484
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $406 |
| Novo Nordisk Inc | 19 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $185 |
| PFIZER INC. | 11 | $163 |
| Lilly USA, LLC | 9 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $144 |
| Antares Pharma, Inc. | 7 | $123 |
| Lundbeck LLC | 6 | $119 |
| Ardelyx, Inc. | 6 | $116 |
| ABBVIE INC. | 4 | $95 |
Products named: CAPLYTA, AIRSUPRA, TRINTELLIX, NURTEC ODT, FARXIGA, Wegovy, IBSRELA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
